Sentinel Node and Recurrent Breast Cancer; Regional staging proposal and registration

Sentinel Node and Recurrent Breast Cancer; Regional staging proposal and registration - SNARB

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33553

Enrollment

150

Registered

2008-01-28

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent mammacarcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Operable cytological /histological confirmed locally recurrent breast cancer -Having obtained an informed consent

Exclusion criteria

Exclusion criteria: -Proven ipsi- or contralateral regional lymph node metastases (ultrasound and FNA) -Known to be allergic to *99mTc-colloidal albumin* or blue dye injection fluids

Design outcomes

Primary

Measure	Time frame
Registration of technical feasibility and validity of lymphatic mapping and sentinel node biopsy in patients with locally recurrent breast cancer as well as registration of lymphatic drainage pathways and sentinel lymph node status. Furthermore, the influence of this staging procedure on therapeutic decisions will be evaluated.	—

Countries

Netherlands

Outcome results